Megace 160 mg tablete
| Name | Megace 160 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-977775077 |
| Active Substance | megestrolacetat |
| Composition | jedna tableta sadrži 160 mg megestrolacetata |
| Pharmaceutical Form | tableta |
| Manufacturer | Haupt Pharma Amareg GmbH, Regensburg, Njemačka |
| Marketing Authorisation Holder | Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 01.06.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/419 |
| Registration Number | 381-12-01/30-20-25 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02AB01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
